Discovery Therapeutics Caribe (DTC) is a clinical-stage biotech firm committed to enhancing the health outcomes of Americans by pioneering regenerative therapies for severe and life-threatening illnesses. DTC's flagship product is an intralesional recombinant human Epidermal Growth Factor (rhEGF) designed to address complex and resistant neuropathic, ischemic, and neuroischemic diabetic foot ulcers (DFU). DTC is developing Heb...
Discovery Therapeutics Caribe (DTC) is a clinical-stage biotech firm committed to enhancing the health outcomes of Americans by pioneering regenerative therapies for severe and life-threatening illnesses. DTC's flagship product is an intralesional recombinant human Epidermal Growth Factor (rhEGF) designed to address complex and resistant neuropathic, ischemic, and neuroischemic diabetic foot ulcers (DFU). DTC is developing Heberprot-P in the United States under a research and collaboration agreement with CIGB.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.